Horm Metab Res 2007; 39(7): 538-541
DOI: 10.1055/s-2007-984351
Short Communication

© Georg Thieme Verlag KG Stuttgart · New York

Modulation of Type 2 Iodothyronine Deiodinase Activity in Rat Thyroid Gland

P. C. Lisboa 1 , A. P. Cabanelas 2 , F. H. Curty 1 , K. J. Oliveira 2 , 3 , T. M. Ortiga-Carvalho 2 , E. G. Moura 1 , C. C. Nascimento-Saba 1 , D. Rosenthal 4 , C. C. Pazos-Moura 2
  • 1Departamento Ciências Fisiológicas, Instituto de Biologia Roberto Alcântara Gomes, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brasil
  • 2Laboratorio Endocrinologia Molecular, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil
  • 3Laboratorio Tecnologia em Bioquímica e Microscopia, Centro Universitário Estadual da Zona Oeste, Rio de Janeiro, Brasil
  • 4Laboratorio Fisiologia Endócrina, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil
Further Information

Publication History

received 21.11.2006

accepted 29.1.2007

Publication Date:
05 July 2007 (online)

Introduction

The majority of biological responses to thyroid hormones require the enzymatic conversion of thyroxine (T4) to triiodothyronine (T3), the bioactive hormone. Two distinct enzymes are responsible for this reaction, namely type 1 and 2 iodothyronine deiodinases (D1 and D2). Based on several functional criteria, D1 and D2 have major kinetic differences and distinct tissue distribution. According to current concepts, D1 and D2 have similar contribution to plasma T3 generation [1].

Thyroid gland has a very high D1 activity and the presence of D2 activity and mRNA expression in both human [1] [2] [3] [4] and rat [5] [6] [7] [8] thyroids have been detected. Although in humans most T3 has extrathyroidal origin, in rats, the thyroid gland contributes with approximately 50% of serum T3 [9], coming not only from the thyroid production but also from intrathyroidal T4 to T3 conversion, catalyzed predominantly by D1. Therefore, the modulation of thyroid deiodination process may have consequences to plasma T3 production in rodents. The stimulatory role of TSH upon thyroid D1 has been well described [1], but there are only few data about the regulation of thyroid deiodination, mainly concerning D2 activity.

In human thyroid, D2 mRNA was found at higher level than in placenta and it was especially high in Graves’ patients and in follicular adenomas, suggesting that intrathyroidal T4 to T3 conversion by D2 contributes to elevate thyroid T3 production [4]. In avian species, D2 is expressed in thyroid in the same level as in brain [10]. We have previously detected [7] that in rats, TSH seems to upregulate D2, as well as D1, since hypothyroidism was associated with high thyroid D2 and D1 activity. However, both thyroid deiodinase activities were decreased in rats submitted to cold exposure for a short period, despite high TSH levels. Leptin modulates thyroid deiodination by increasing D1 activity, but was not able to change D2 activity [7].

Here we studied the response of thyroid D2 activity, and in parallel that of D1, to sexual dimorphism, gonadectomy, fasting, and diabetes mellitus, since in rodents, the thyroid is very important for generating serum T3 and very little is known about thyroid D2 regulation.

References

  • 1 Bianco AC, Salvatore D, Gereben B, Berry M, Larsen PR. Endocr Rev. 2002;  23 38-89
  • 2 Murakami M, Araki O, Hosoi Y, Kamiya Y, Morimura T, Ogiwara T, Mizuma H, Mori M. Endocrinology. 2001;  142 2961-2967
  • 3 Salvatore D, Bartha T, Harney JW, Larsen PR. Endocrinology. 1996;  137 3308-3315
  • 4 Salvatore D, Tu H, Harney JW, Larsen PR. J Clin Invest. 1996;  98 962-968
  • 5 Bates JM, St Germain DL, Galton VA. Endocrinology. 1999;  140 844-850
  • 6 Dutra SC, Passos MC, Lisboa PC, Santos RS, Cabanelas AP, Pazos- Moura CC, Moura EG. Horm Metab Res. 2003;  35 268-270
  • 7 Lisboa PC, Oliveira KJ, Cabanelas A, Ortiga-Carvalho TM, Pazos-Moura CC. Am J Physiol Endocrinol Metab. 2003;  284 E1172-E1176
  • 8 Lisboa PC, Passos MC, Dutra SC, Santos R, Bonomo IT, Cabanelas AP, Pazos-Moura CC, Moura EG. J Endocrinol. 2003;  177 261-267
  • 9 Chanoine JP, Braverman LE, Farwell AP, Safran M, Alex S, Dubord S, Leonard JL. J Clin Invest. 1993;  91 2709-2713
  • 10 Gereben B, Bartha T, Tu HM, Harney JW, Rudas P, Larsen PR. J Biol Chem. 1999;  274 13768-13776
  • 11 Wu SY. Acta Endocrinol (Copenh). 1990;  122 175-180
  • 12 Lisboa PC, Curty FH, Moreira RM, Pazos-Moura CC. Braz J Med Biol Res. 1997;  30 1479-1484
  • 13 Costa VM da, Moreira DG, Rosenthal D. J Endocrinol. 2001;  171 193-198

Correspondence

Dr. P. C.Lisboa 

Departamento de Ciências Fisiológicas - 5o andar

Instituto de Biologia

Universidade do Estado do Rio de Janeiro

Av. 28 de setembro

87-Rio de Janeiro

20551-030 RJ

Brazil

Phone: +55/21/2587 61 34

Fax: +55/21/2587 61 29

Email: pclisboa@uerj.br

Email: patricialisboa@pesquisador.cnpq.br

    >